Skip to main content
. 2021 Dec 15;11(6):443–475.

Figure 6.

Figure 6

Post-therapy, 68Ga-DOTA-NOC PET scans in a 57-year-old man with pancreatic neuroendocrine tumor with extensive liver metastases. The patient was treated with four cycles of 177Lu-DOTATATE and on regular follow-up showed significant decreases in both the primary tumor in the pancreas and hepatic metastases. Adapted from Ref [88].